中文 | English
Return
Total: 104 , 1/11
Show Home Prev Next End page: GO
Author:(Jia-Sen XU)

1.Conserved translational control in cardiac hypertrophy revealed by ribosome profiling.

Bao-Sen WANG ; Jian LYU ; Hong-Chao ZHAN ; Yu FANG ; Qiu-Xiao GUO ; Jun-Mei WANG ; Jia-Jie LI ; An-Qi XU ; Xiao MA ; Ning-Ning GUO ; Hong LI ; Zhi-Hua WANG

Acta Physiologica Sinica 2025;77(5):757-774

2.RNA G-quadruplex (rG4) exacerbates cellular senescence by mediating ribosome pausing.

Haoxian ZHOU ; Shu WU ; Bin LI ; Rongjinlei ZHANG ; Ying ZOU ; Mibu CAO ; Anhua XU ; Kewei ZHENG ; Qinghua ZHOU ; Jia WANG ; Jinping ZHENG ; Jianhua YANG ; Yuanlong GE ; Zhanyi LIN ; Zhenyu JU

Protein & Cell 2025;16(11):953-967

3.Independent and Interactive Effects of Air Pollutants, Meteorological Factors, and Green Space on Tuberculosis Incidence in Shanghai.

Qi YE ; Jing CHEN ; Ya Ting JI ; Xiao Yu LU ; Jia le DENG ; Nan LI ; Wei WEI ; Ren Jie HOU ; Zhi Yuan LI ; Jian Bang XIANG ; Xu GAO ; Xin SHEN ; Chong Guang YANG

Biomedical and Environmental Sciences 2025;38(7):792-809

5.Genome-wide identification, characterization, and expression analysis of MAPK genes in response to Plasmodiophora brassicae infection in Brassica juncea.

Chu XU ; Haiping WANG ; Jiangping SONG ; Xiaohui ZHANG ; Huixia JIA ; Jiaqi HAN ; Zhijie LI ; Sen LI ; Wenlong YANG

Chinese Journal of Biotechnology 2025;41(2):736-752

6.Resveratrol alleviates the immune response and proliferation of macrophages induced by homocysteine

Xue-Sen ZHANG ; Kai-Yue QIN ; Xiao-Han LI ; Yan-Jia WANG ; Xi XU ; Xiao-Ling YANG

The Chinese Journal of Clinical Pharmacology 2024;40(14):2038-2042

8.Epidemiological characteristics of high-risk population for cardiovascular disease of Shanghai residents

Yuzhuo WANG ; Yang ZHENG ; Yingquan WANG ; Cui WU ; Haiyan GU ; Yiying ZHANG ; Yan XU ; Sen WANG ; Xin ZHANG ; Yu JIANG ; Jia ZHAO ; Yan SHI

Shanghai Journal of Preventive Medicine 2024;36(1):64-71

9.Efficacy and safety of LY01005 versus goserelin implant in Chinese patients with prostate cancer: A multicenter, randomized, open-label, phase III, non-inferiority trial.

Chengyuan GU ; Zengjun WANG ; Tianxin LIN ; Zhiyu LIU ; Weiqing HAN ; Xuhui ZHANG ; Chao LIANG ; Hao LIU ; Yang YU ; Zhenzhou XU ; Shuang LIU ; Jingen WANG ; Linghua JIA ; Xin YAO ; Wenfeng LIAO ; Cheng FU ; Zhaohui TAN ; Guohua HE ; Guoxi ZHU ; Rui FAN ; Wenzeng YANG ; Xin CHEN ; Zhizhong LIU ; Liqiang ZHONG ; Benkang SHI ; Degang DING ; Shubo CHEN ; Junli WEI ; Xudong YAO ; Ming CHEN ; Zhanpeng LU ; Qun XIE ; Zhiquan HU ; Yinhuai WANG ; Hongqian GUO ; Tiwu FAN ; Zhaozhao LIANG ; Peng CHEN ; Wei WANG ; Tao XU ; Chunsheng LI ; Jinchun XING ; Hong LIAO ; Dalin HE ; Zhibin WU ; Jiandi YU ; Zhongwen FENG ; Mengxiang YANG ; Qifeng DOU ; Quan ZENG ; Yuanwei LI ; Xin GOU ; Guangchen ZHOU ; Xiaofeng WANG ; Rujian ZHU ; Zhonghua ZHANG ; Bo ZHANG ; Wanlong TAN ; Xueling QU ; Hongliang SUN ; Tianyi GAN ; Dingwei YE

Chinese Medical Journal 2023;136(10):1207-1215

10.Melatonin alleviates alcoholic liver disease via EGFR-BRG1-TERT axis regulation.

Zhaodi CHE ; Yali SONG ; Chengfang XU ; Wei LI ; Zhiyong DONG ; Cunchuan WANG ; Yixing REN ; Kwok-Fai SO ; George L TIPOE ; Fei WANG ; Jia XIAO

Acta Pharmaceutica Sinica B 2023;13(1):100-112

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 104 , 1/11 Show Home Prev Next End page: GO